Cardionet (BEAT) 12.69 $BEAT New Strong Buy Stocks for

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Cardionet (BEAT) 12.69 $BEAT

New Strong Buy Stocks for November 16th
Zacks Equity Research - Zacks Investment Research - Mon Nov 16, 8:30AM CST
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Monday
BEAT: 12.69 (-0.38), BBEP: 2.11 (-0.09), BBY: 30.93 (-0.70), BNCL: 13.68 (-0.02), BITA: 28.21 (-0.33)

Zacks Investment Ideas feature highlights: AMN Healthcare Services, BioTelemetry, Healthequity, INC Research Holdings and PRA Health Sciences
Zacks Equity Research - Zacks Investment Research - Fri Nov 13, 8:30AM CST
Zacks Investment Ideas feature highlights: AMN Healthcare Services, BioTelemetry, Healthequity, INC Research Holdings and PRA Health Sciences
HQY: 32.41 (-0.45), BEAT: 12.69 (-0.38), INCR: 46.62 (+1.25), AHS: 29.51 (+0.11), PRAH: 43.36 (+1.61)

Top 5 Medical Service Stocks to Buy
Brian Hamilton - Zacks Investment Research - Thu Nov 12, 2:55PM CST
Top 5 Medical Service Stocks to Buy
BEAT: 12.69 (-0.38), HQY: 32.41 (-0.45), INCR: 46.62 (+1.25), AHS: 29.51 (+0.11), PRAH: 43.36 (+1.61)

BioTelemetry, Inc. Reports Third Quarter 2015 Financial Results
GlobeNewswire - Mon Nov 09, 3:05PM CST
BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today reported results for the third quarter ended September 30, 2015.
BEAT: 12.69 (-0.38)

Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan
at The Street - Fri Nov 06, 7:17PM CST
Cramer will be watching for earnings from Priceline, McDonald's and Macy's in another busy week.
DHI: 31.55 (+0.16), KSS: 44.36 (+0.42), NMM: 4.50 (-0.35), M: 37.89 (-0.73), XOM: 80.51 (-0.39), JPM: 66.33 (-0.18), BC: 53.13 (-0.28), CMI: 98.81 (-0.32), AAC: 22.93 (+0.35), RRMS: 19.80 (-0.43), NAT: 14.99 (-0.41), FGP: 19.66 (-0.45), HIMX: 6.95 (+0.21), CSCO: 27.00 (+0.21), NEO: 7.62 (+0.04), PFE: 33.24 (+0.08), DIS: 116.71 (+0.79), COP: 54.11 (-0.26), WFC: 55.24 (-0.03), BAC: 17.47 (+0.04), PCLN: 1,258.70 (-8.17), PM: 84.23 (-0.12), LCI: 36.02 (+0.65), LRCX: 77.99 (+0.58), BEAT: 12.69 (-0.38), JCP: 7.44 (-0.19), JWN: 54.48 (-0.25), MCD: 111.10 (+0.04), MRO: 17.78 (-0.09), KLAC: 66.73 (+0.38), CVX: 91.50 (+0.05), VIAB: 50.85 (-1.12)

Be on Top of the Latest Developments - Research on BioTelemetry, Pericom Semiconductor, United Insurance Holdings Corp and Extreme Networks
ACCESSWIRE - Thu Nov 05, 6:50AM CST
NEW YORK, NY / ACCESSWIRE / November 5, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: BioTelemetry Inc. (NASDAQ: BEAT), Pericom Semiconductor Corp (NASDAQ: PSEM), United Insurance Holdings Corp (NASDAQ: UIHC) and Extreme Networks Inc. (NASDAQ: EXTR). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
UIHC: 18.60 (-0.17), PSEM: 17.72 (+0.01), BEAT: 12.69 (-0.38), EXTR: 3.81 (+0.02)

BioTelemetry, Inc. to Release Third Quarter 2015 Earnings Results on November 9, 2015
GlobeNewswire - Fri Oct 30, 7:30AM CDT
BioTelemetry, Inc. (NASDAQ:BEAT) will release its third quarter 2015 earnings on Monday, November 9, 2015 at 4:00 PM Eastern Time.
BEAT: 12.69 (-0.38)

Market Has a Mood Swing to the Upside
at The Street - Thu Oct 15, 3:12PM CDT
Gloom is gone as likelihood of Fed rate hike fades.
BLUE: 81.84 (+7.39), NFLX: 117.18 (+5.83), EYES: 5.41 (+0.02), TRVN: 10.93 (-0.01), ESPR: 26.13 (-0.77), FB: 105.55 (+1.51), BEAT: 12.69 (-0.38), WMT: 60.10 (+2.23), ONTY: 3.33 (-0.02)

'Bad News Is Good News' Is Working
at The Street - Thu Oct 15, 12:43PM CDT
Sorry, bears, but downside market momentum hasn't materialized.
BLUE: 81.84 (+7.39), NFLX: 117.18 (+5.83), EYES: 5.41 (+0.02), TRVN: 10.93 (-0.01), ESPR: 26.13 (-0.77), FB: 105.55 (+1.51), BEAT: 12.69 (-0.38), WMT: 60.10 (+2.23), ONTY: 3.33 (-0.02)

Can 'Bad News Is Good' Continue to Work?
at The Street - Thu Oct 15, 9:45AM CDT
The bulls are more worried about catching a lift then they are about being logical.
BLUE: 81.84 (+7.39), NFLX: 117.18 (+5.83), EYES: 5.41 (+0.02), TRVN: 10.93 (-0.01), ESPR: 26.13 (-0.77), FB: 105.55 (+1.51), BEAT: 12.69 (-0.38), WMT: 60.10 (+2.23), ONTY: 3.33 (-0.02)

Flow of Bad News Pours Over Market
at The Street - Wed Oct 14, 3:17PM CDT
Wal-Mart sets the tone, but selling hasn't been bad enough to kill rally.
BLUE: 81.84 (+7.39), AMZN: 646.50 (-1.31), TRVN: 10.93 (-0.01), TSLA: 214.01 (-0.30), FB: 105.55 (+1.51), WMT: 60.10 (+2.23), BAC: 17.47 (+0.04), WFC: 55.24 (-0.03), GNCA: 6.05 (+0.14), BA: 145.89 (+1.47), INTC: 32.68 (+0.58), ONTY: 3.33 (-0.02), ASML: 92.49 (+0.20), NFLX: 117.18 (+5.83), ESPR: 26.13 (-0.77), JPM: 66.33 (-0.18), BEAT: 12.69 (-0.38), GOOGL: 751.41 (+0.99), IWM: 114.83 (-0.22), AAPL: 114.04 (-0.14)

A Market Malaise
at The Street - Wed Oct 14, 12:37PM CDT
But the mood shifts quite fast on upticks.
BLUE: 81.84 (+7.39), TRVN: 10.93 (-0.01), TSLA: 214.01 (-0.30), FB: 105.55 (+1.51), BAC: 17.47 (+0.04), WFC: 55.24 (-0.03), GNCA: 6.05 (+0.14), INTC: 32.68 (+0.58), ONTY: 3.33 (-0.02), ASML: 92.49 (+0.20), NFLX: 117.18 (+5.83), ESPR: 26.13 (-0.77), JPM: 66.33 (-0.18), BEAT: 12.69 (-0.38), GOOGL: 751.41 (+0.99), AAPL: 114.04 (-0.14)

PRA Health: Strong Buy on Q2 Results, Recent Developments
Zacks Equity Research - Zacks Investment Research - Tue Oct 13, 11:30AM CDT
On Oct 10, Zacks Investment Research upgraded PRA Health Sciences Inc. (PRAH) to a Zacks Rank #1 (Strong Buy).
ICUI: 113.32 (+1.84), BEAT: 12.69 (-0.38), PRAH: 43.36 (+1.61), MDAS: 29.89 (-0.42)

12.4% Return Seen to Date on SmarTrend CardioNet Call (BEAT)
Comtex SmarTrend(R) - Fri Oct 09, 10:06AM CDT
SmarTrend identified a Downtrend for CardioNet (NASDAQ:BEAT) on September 24th, 2015 at $13.74. In approximately 2 weeks, CardioNet has returned 12.37% as of today's recent price of $12.04.
BEAT: 12.69 (-0.38)

New Strong Buy Stocks for October 9th
Zacks Equity Research - Zacks Investment Research - Fri Oct 09, 8:30AM CDT
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Friday
ARCX: 14.40 (+0.90), BAX: 37.65 (-0.28), BEAT: 12.69 (-0.38), AMSWA: 9.75 (-0.10), ADPT: 49.51 (-10.36)

BioTelemetry, Inc. Announces Its Latest Success in Patent Enforcement
GlobeNewswire - Tue Oct 06, 7:00AM CDT
BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, is pleased to announce that the Honorable Juan R. Sanchez of the Eastern District of Pennsylvania has issued an October 2, 2015 Order finding MedTel24, Inc. ("MedTel" in contempt of a Consent Judgment previously issued by the Court. The previously issued Consent Judgment declared all five asserted BioTelemetry patents valid, enforceable and infringed by MedTel. The Consent Judgment also declared that MedTel is permanently enjoined from further infringement and is required to deliver to BioTelemetry all software, source code, hardware, and documentation relating to the Heartrak ECAT system.
BEAT: 12.69 (-0.38)

Using Bottom Fishing to BEAT the Market
at The Street - Sat Oct 03, 11:00AM CDT
I'm taking advantage of low prices to buy BioTelemetry Inc. (BEAT).
BEAT: 12.69 (-0.38)

Intrexon (XON) Falls: Stock Goes Down 5.4%
Zacks Equity Research - Zacks Investment Research - Fri Oct 02, 7:55AM CDT
Intrexon saw a big move last session, continuing the downward trend for the stock as the shares are down about 40% since Sep 18
BEAT: 12.69 (-0.38), XON: 35.61 (+0.67)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Encompass Health: Leader in Rehabilitation Again in 2026

Updated Category News Views 11

Pinnacle of Rehab: Encompass Health's Notable Streak You know, in a world where healthcare accolades fly around like confetti, Encompass Health Corp's persistence in being named America's Most Awarded Leader in Inpatient Rehabilitation by Newsweek for the seventh straight year is something to chew on. The fact that a record 78 of its hospitals dotted across 32 states...

Continue Reading
Chemours Faces Investor Fraud Suit: Action Needed Now

Updated Category News Views 10

A Messy Situation Unfolds for Chemours Company You know, stumbling upon a battle scene like this isn't something I enjoy, but here we have Chemours Company (NYSE: CC) embroiled in a securities fraud lawsuit. It's like catching wind of a brawl outside your favorite tavern—can't ignore it, can you? The Lawsuit's Crux and Key Dates to Watch Here's the rundown. The fight...

Continue Reading
Nomada Fund Launches: A Game-Changer in New Media

Updated Category News Views 14

Changing the Investment Game In a world where tech isn't the only kingmaker, distribution is the new play. Welcome the Nomada Fund, a fresh face on the investment scene that's swapping cash for exposure. Forget the traditional media-for-equity model that only old-timers still drool over—these guys are taking it up a notch with their new Distribution for Equity approach,...

Continue Reading
Nest Health Appoints Peter Morrison for Multistate Expansion

Updated Category News Views 11

Peter Morrison Steps Up as Chief Growth Officer You know, it's not every day you see a move as gutsy as Nest Health's recent appointment of Peter Morrison. They're shaking up the Medicaid space, aiming to redefine primary care for families with limited resources. Morrison, coming from heavyweights like UnitedHealthcare and Centene, isn't your typical pencil-pusher. He’s...

Continue Reading
Clean Power Alliance's Bond Deal Secures $91M Savings

Updated Category News Views 11

CPA Triumphs Yet Again With Bond Savings I'll tell you, the Clean Power Alliance (CPA) just hit the jackpot again. We're talking a $1.4 billion energy prepayment bond deal that locks in a whopping $91.1 million in savings over the next seven years. Not bad, huh? A Closer Look at the Numbers CPA's charm—besides being the top green power supplier in the U.S.—is spinning...

Continue Reading
TilePix Expands into Walmart with Nail-Free Decor Launch

Updated Category News Views 11

TilePix Makes Big Moves with Walmart TilePix is launching their new line of nail-free wall décor at Walmart—this ain’t your grandma’s wall art. This company's bringing their magnetic, nail-free wizardry to retail stores nationwide for the first time, and they’ve chosen a real heavyweight partner—Walmart. What comes in the package? Well, they’re dealing in...

Continue Reading
Florida Cancer Center Expands Expertise with New Oncologist

Updated Category News Views 10

Welcoming a Highly Skilled Oncologist to Fort Myers There's an old saying in the world of investing: follow the expertise. And when it comes to healthcare, especially cancer treatment, expertise can make a world of difference. Florida Cancer Specialists & Research Institute (FCS) is throwing its hat in the ring with authority, as they welcome Dr. Kelly Elleson, a surgical...

Continue Reading
FLUX 3 Max Launches with Unmatched Speed and Quality

Updated Category News Views 14

A Lightning Fast Leap in Video Generation It's all eyes on FLUX 3 Max today. You can almost hear the gasps of 'wow' in the generative media crowd. Why? Because this new weapon in the video gen arsenal, dreamed up by fal and Black Forest Labs, is slicing through the old speed limits like a blistering comet. Now, don't get me wrong. Seeds don't grow overnight, and neither...

Continue Reading
GELITA Showcases Collagen Innovations at SupplySide 2026

Updated Category News Views 23

Collagen Solutions Front and Center First up, a little chat about collagen might be in order. For folks not tied into the science side, it sounds like a trendy wellness potion. But here comes GELITA at SupplySide Global 2026, showing it's the real McCoy. Nestled in Booth #4565, they're laying out a spread of next-gen collagen innovations aimed at everything from wound...

Continue Reading
Honeywell Aerospace Faces Securities Fraud Lawsuit

Updated Category News Views 8

Turning Up the Heat on Honeywell Alright, strap in because things are getting tense over at Honeywell Aerospace (NASDAQ:HONA). Schall, Brown & Schwartz LLP (SBS) is stirring the pot with a class action lawsuit alleging some pretty deceptive business going-ons. From securities violations to misleading market statements, they aren’t holding back any punches. What’s This...

Continue Reading

Top 5 Most Recently Viewed Articles

Introducing IZZY: The AI Assistant in Influencer Marketing

Updated Category News Views 276

IZEA Introduces IZZY: The AI Assistant for Influencer Marketing IZEA Worldwide, Inc. (NASDAQ: IZEA), a frontrunner in technology, data, and services for the Creator Economy, has unveiled IZZY, a groundbreaking AI assistant tailored for influencer marketing professionals. This powerful tool is now accessible to users of IZEA Flex, IZEA's all-encompassing influencer...

Continue Reading
Empowering Women's Health: Doina Dragusanu's New Initiative

Updated Category News Views 83

Transformative Wellness Program for Women Facing Menopause Holistic, evidence-based support is now available for women aged 40–65 to manage menopause symptoms and reclaim wellness. With over a billion women globally predicted to face menopause in the coming years, Doina-Mihaela Dragusanu, a nurse and certified menopause coach, has developed a six-month program aimed...

Continue Reading
Marine Petroleum Trust Declares Higher Quarterly Distribution

Updated Category News Views 84

Marine Petroleum Trust's Latest Cash Distribution Announcement Marine Petroleum Trust (NASDAQ: MARPS) has announced the declaration of a quarterly cash distribution to its unit holders. This distribution stands at $0.102923 per unit, marking a notable increase when compared to the previous quarter's distribution of $0.094886 per unit. The payment is scheduled for December...

Continue Reading
Exciting Growth Forecast for Forklift Trucks Market Through 2028

Updated Category News Views 91

Exciting Growth Forecast for Forklift Trucks Market Through 2028 The global forklift trucks market is on the brink of significant expansion, anticipating a remarkable growth of approximately USD 23.26 billion from 2024 to 2028. In analyzing this sector, experts project a compound annual growth rate (CAGR) of around 7.2% throughout the forecast period. The driving force...

Continue Reading
Clarity Pharmaceuticals Celebrates Milestone in Prostate Cancer Research

Updated Category News Views 92

Clarity Pharmaceuticals Marks a Significant Achievement in Urology Clarity Pharmaceuticals (ASX: CU6), a pioneering clinical-stage radiopharmaceutical company, has received notable recognition for its groundbreaking research into prostate cancer through an abstract acceptance for oral presentation at the upcoming European Association of Urology (EAU) Congress 2026. This...

Continue Reading